Ameritas Investment Partners, Inc. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$84,535
+54.0%
1,456
+42.7%
0.00%
+50.0%
Q2 2023$54,907
+35.5%
1,0200.0%0.00%0.0%
Q1 2023$40,514
-7.6%
1,0200.0%0.00%0.0%
Q4 2022$43,840
+75.4%
1,020
+30.6%
0.00%
+100.0%
Q3 2022$25,000
+8.7%
7810.0%0.00%0.0%
Q2 2022$23,000
+4.5%
7810.0%0.00%0.0%
Q1 2022$22,000
-38.9%
7810.0%0.00%0.0%
Q4 2021$36,000
+38.5%
7810.0%0.00%0.0%
Q3 2021$26,000
-3.7%
7810.0%0.00%0.0%
Q2 2021$27,000
-3.6%
7810.0%0.00%0.0%
Q1 2021$28,000
+21.7%
7810.0%0.00%0.0%
Q4 2020$23,000
+4.5%
7810.0%0.00%0.0%
Q3 2020$22,000
-12.0%
7810.0%0.00%0.0%
Q2 2020$25,000
-21.9%
7810.0%0.00%
-50.0%
Q1 2020$32,000
-33.3%
7810.0%0.00%0.0%
Q4 2019$48,000
-15.8%
7810.0%0.00%
-33.3%
Q3 2019$57,000
-10.9%
7810.0%0.00%0.0%
Q2 2019$64,000
+48.8%
781
+26.8%
0.00%
+50.0%
Q1 2019$43,000
+53.6%
6160.0%0.00%0.0%
Q4 2018$28,000
-20.0%
6160.0%0.00%0.0%
Q3 2018$35,000
-14.6%
6160.0%0.00%0.0%
Q2 2018$41,000
+13.9%
6160.0%0.00%0.0%
Q1 2018$36,000
-10.0%
6160.0%0.00%0.0%
Q4 2017$40,000
+37.9%
6160.0%0.00%
+100.0%
Q3 2017$29,0000.0%6160.0%0.00%0.0%
Q2 2017$29,000
-3.3%
6160.0%0.00%0.0%
Q1 2017$30,0006160.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders